| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $32.9M | +25.1% |
| Cost of Revenue | $16.8M | +78.3% |
| Gross Profit | $16.1M | -4.6% |
| R&D Expense | $6.3M | +62.2% |
| SG&A Expense | $6.6M | -27.6% |
| Operating Income | -$37.8M | -82.1% |
| Interest Expense | -$7.4M | -347.7% |
| Pre-tax Income | -$49.2M | -86.2% |
| Income Tax | -$9K |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.0M | -84.4% |
| Accounts Receivable | $1.2M | +140.0% |
| Inventory | $302K | +5.5% |
| Current Assets | $59.2M | -48.8% |
| Total Assets | $97.7M | -26.4% |
| Current Liabilities | $36.7M | +36.9% |
| Long-term Debt | $61.7M | +4.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.3M | +65.6% |
| Capital Expenditures | $162K | +2.2% |
| Investing Cash Flow | -$47.6M | -1692.1% |
| Financing Cash Flow | -$10.0M | -108.7% |
| Free Cash Flow | -$9.5M | +65.2% |
| -277.4% |
| Net Income | -$49.2M | -86.1% |
| Total Liabilities |
| $99.6M |
| +14.2% |
| Stockholders' Equity | -$1.9M | -104.2% |